SCHEMBL30066615

SCHEMBL30066615

CCCCOC(=O)CCCN1CCNCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH2 P25021 6/20 0.56
▸ HRH1 P35367 6/20 0.56
▸ DGKA P23743 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ RECQL P46063 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ SIGMAR1 Q99720 1/20 0.41
▸ ITGB3 P05106 1/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM5 P08912 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29001314 0.94 HRH2 (0.54) HRH2HRH1DGKALMNATHRB
SCHEMBL6606038 0.92 HRH2 (0.54) HRH2HRH1DGKAMAPTMAPK1
SCHEMBL11712690 0.91 HRH2 (0.60) HRH2HRH1DGKAALDH1A1
SCHEMBL11779963 0.91 HRH2 (0.60) HRH2HRH1DGKAALDH1A1
Hydrochloric Acid SCHEMBL31722504 0.91 HRH2 (0.53) HRH2HRH1DGKAMAPTMAPK1
SCHEMBL11337135 0.87 DGKA (0.57) HRH2HRH1DGKAMAPTALDH1A1
SCHEMBL11337142 0.87 DGKA (0.57) HRH2HRH1DGKAMAPTALDH1A1
SCHEMBL20057624 0.87 DGKA (0.57) HRH2HRH1DGKAMAPTALDH1A1
SCHEMBL3573043 0.86 CYP1A2 (0.46) HRH2HRH1ALDH1A1MEN1KMT2A
SCHEMBL19034571 0.86 DGKA (0.50) HRH2HRH1DGKAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334303-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE Nurix Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback